Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.88K Hold
22
﹤0.01% 121
2026
Q1
$7.6K Buy
22
+1
+5% +$356 ﹤0.01% 117
2025
Q4
$7.02K Hold
21
﹤0.01% 116
2025
Q3
$6.01K Hold
21
﹤0.01% 124
2025
Q2
$5.9K Hold
21
﹤0.01% 120
2025
Q1
$6.53K Buy
21
+10
+91% +$2.95K ﹤0.01% 126
2024
Q4
$2.81K Hold
11
﹤0.01% 148
2024
Q3
$3.45K Hold
11
﹤0.01% 161
2024
Q2
$3.32K Hold
11
﹤0.01% 140
2024
Q1
$2.99K Buy
11
+1
+10% +$293 ﹤0.01% 129
2023
Q4
$3.02K Hold
10
﹤0.01% 149
2023
Q3
$2.79K Hold
10
﹤0.01% 150
2023
Q2
$2.29K Hold
10
﹤0.01% 134
2023
Q1
$2.47K Hold
10
﹤0.01% 136
2022
Q4
$2.66K Buy
10
+5
+100% +$1.34K ﹤0.01% 137
2022
Q3
$1K Hold
5
﹤0.01% 130
2022
Q2
$1K Hold
5
﹤0.01% 137
2022
Q1
$1K Buy
+5
New +$1.15K ﹤0.01% 141

Other funds holding AMGN

Financial Avengers's AMGN Position: Q2 2026 in Review

Financial Avengers held its Amgen (AMGN) position steady in Q2 2026 at 22 shares worth $7.88K. The position accounts for ﹤0.01% of the portfolio, ranked #121.

Financial Avengers first reported a position in AMGN in Q1 2022 and has held it in 18 quarters since. 3,157 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Financial Avengers held 22 shares of Amgen worth $7.88K as of Q2 2026.
  • Financial Avengers left its Amgen share count unchanged in Q2 2026.
  • Amgen made up ﹤0.01% of Financial Avengers's portfolio in Q2 2026, its #121 holding.
  • Financial Avengers first reported a position in Amgen in Q1 2022 and has held it in 18 quarters since.
  • 3,157 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Financial Avengers's 13F filing for Q2 2026, filed 19 Aug 2026.